PFM
BEAM icon

Premier Fund Managers’s Beam Therapeutics BEAM Stock Holding History

Premier Fund Managers’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82K Buy
+2,332
New +$70.4K 0.01% 166

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Premier Fund Managers's BEAM Position: Q2 2026 in Review

Premier Fund Managers opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 2,332 shares worth $82K. The stake represents 0.01% of the portfolio and ranks #166 among its holdings.

277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Premier Fund Managers held 2,332 shares of Beam Therapeutics worth $82K as of Q2 2026.
  • Beam Therapeutics was a new Premier Fund Managers position in Q2 2026.
  • Beam Therapeutics made up 0.01% of Premier Fund Managers's portfolio in Q2 2026, its #166 holding.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Premier Fund Managers's 13F filing for Q2 2026, filed 22 Jul 2026.